Menu
No results found.
063160
CKD Bio Corp. – KRX
Weekly Share Price & Valuation Overview
Market Overview
Open
23200.0000
Close
22850.0000
High
23200.0000
Low
22750.0000
Trend
0.60651
CKD Bio Corp.
South Korea
• KRX - Korea Stock Exchange
• 063160
• Currency: KRW
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Key strengths
- Revenue growth ≥10% indicates solid top-line momentum.
Potential weaknesses
- Quick ratio <0.8 — tight near-term liquidity without inventory.
- Negative free cash flow — operations may rely on external financing.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- KRW 125.08B
- Enterprise Value Operating value: market cap + total debt − cash.
- KRW 271.86B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- KRW 159.93B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- KRW 6.95B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- KRW -7.40B
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- KRW 29.15K
- Shares Outstanding
- 5.49M
- Float Shares
- 3.34M
- Implied Shares Outstanding
- 5.50M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
-13.43%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
-4.63%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
4.35%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
-14.46%
- ROA Return on assets: net income ÷ total assets.
-
-4.96%
- ROE Return on equity: net income ÷ shareholder equity.
-
-16.26%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Strong Year-over-year revenue growth.
-
12.60%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
- 0.65
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 1.21
- Total Cash Cash and equivalents.
- KRW 12.35B
- Total Debt Short + long-term interest-bearing debt.
- KRW 159.13B
- Net Debt Total debt − cash (negative = net cash).
- KRW 146.78B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- -21.51
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- KRW -16.59B
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- KRW -15.08B
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
-10.37%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-9.43%
- Cash Conversion (OpCF/EBITDA)
- 2.24
Sharemaestro House View
Confidence: 1
Sharemaestro internal conviction (0–3, higher is better).
Risk: 1
Sharemaestro internal risk profile (0–3, higher is safer).
Composite Score: 1
Overall internal composite (0–3, higher is better).
Suggested Allocation: 1.67%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
60.8%
Insiders
Shares held by company insiders (officers, directors).
39.2%
Institutions
Shares held by institutions (funds, pensions).
0.5%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
0.2%
Net Debt
Total debt − cash (negative = net cash).
KRW 146.78B
91.8% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
72
Methodology Notes
- Dividend Yield suppressed due to an anomalous value from the feed (>30%).
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 03:48
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
AI generated insights not available yet. Sign in to generate the snapshot.